Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging
- 24 April 2011
- journal article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 28 (4) , 763-772
Abstract
Whether the left ventricular (LV) mass index (LVMI) and LV volumetric parameters are associated independently with natriuretic peptide levels is unclear in hypertrophic cardiomyopathy (HCM). Therefore, we investigated which parameters have an independent relationship with N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in HCM patients using echocardiography and cardiac magnetic resonance imaging (CMR). A total of 103 patients with HCM (82 men, age 53 ± 12 years) were evaluated. Echocardiographic evaluations included left atrial volume index (LAVI) and early diastolic mitral inflow E velocity to early annular Ea velocity ratio (E/Ea). LVMI, maximal wall thickness and LV volumetric parameters were measured using CMR. The median value of NT-proBNP level was 387.0 pg/ml. The mean NT-proBNP level in patients with non-apical HCM (n = 69; 36 patients with asymmetric septal hypertrophy, 11 with diffuse, and 22 with mixed type) was significantly higher than in those with apical HCM (n = 34, P < 0.001). NT-proBNP level was negatively correlated with LV end-diastolic volume (LVEDV) (r = −0.263, P = 0.007) and positively with LVMI (r = 0.225, P = 0.022) and maximal wall thickness (r = 0.495, P < 0.001). Among the echocardiographic variables, LAVI (r = 0.492, P < 0.001) and E/Ea (r = 0.432, P < 0.001) were correlated with NT-proBNP. On multivariable analysis, non-apical HCM, increased maximal wall thickness and LAVI were independently related with NT-proBNP. Severity of LV hypertrophy and diastolic parameters might be important in the elevation of NT-proBNP level in HCM. Therefore, further evaluation of these parameters in HCM might be warranted.Keywords
This publication has 24 references indexed in Scilit:
- Relationship Between Serum Biochemical Markers of Myocardial Fibrosis and Diastolic Function at Rest and With Exercise in Hypertrophic CardiomyopathyKorean Circulation Journal, 2009
- Differentiation of Hypertrophic Cardiomyopathy from Other Forms of Left Ventricular Hypertrophy by Means of Three-Dimensional EchocardiographyThe American Journal of Cardiology, 2008
- Significance of Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide on Left Ventricular Remodeling in Non-Obstructive Hypertrophic Cardiomyopathy Attributable to the Asp175Asn Mutation in the α-Tropomyosin GeneThe American Journal of Cardiology, 2008
- Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2007
- Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide to Predict Clinical Course in Patients With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2006
- Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide Levels to Predict Exercise Capacity in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2006
- B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart FailureJACC, 2006
- Plasma amino-terminal pro–B-type natriuretic peptide quantification in hypertrophic cardiomyopathyAmerican Heart Journal, 2005
- Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic CardiomyopathyCirculation, 2004
- EditorialThe American Journal of Cardiology, 1998